Reviewed 10 November 2026 for medical education. This is not an individualized prescribing guide; refer to current local product labels and qualified clinicians.
Overview
Methadone is a fully synthetic diphenylheptane opioid with full mu-opioid agonist activity, used for OUD treatment within regulated programs and, in separate labeled formulations, selected severe persistent pain. It is not a routine first-choice opioid for acute pain. Its delayed accumulation and variable elimination make induction and titration particularly hazardous without experienced supervision [1,2].
Mechanisms of action
Mu-opioid receptor activation suppresses pain signaling and withdrawal symptoms through Gi/o mechanisms. Methadone also has NMDA-antagonist and monoamine-related effects, but the significance of these properties varies and should not be presented as the main basis for OUD treatment. It does not have a well-established clinically useful kappa/delta antagonist profile that would justify its selection over other opioids [1].
Indications and OUD evidence
Methadone maintenance is an effective, often long-term treatment for OUD, reducing illicit opioid use, overdose and mortality. In the United States, methadone dispensing for OUD generally occurs through certified opioid treatment programs under applicable laws; other jurisdictions use different frameworks. Pain-management dosing and OUD-maintenance dosing are not interchangeable. Care plans should include psychosocial support when available, infectious-disease prevention and overdose education [2].
Unpredictable pharmacokinetics
Methadone has high oral bioavailability, extensive tissue distribution and a variable, often prolonged elimination half-life that may far exceed the duration of analgesia. Respiratory depression can peak later and persist longer than apparent analgesia, creating accumulation risk with repeated doses. Metabolism involves multiple enzymes, prominently CYP2B6 with variable contributions from CYP3A4 and others; new inhibitors, inducers or discontinuation of interacting drugs can rapidly alter safety [1,2].
Major boxed warnings and QT prolongation
2026 US METHADOSE labeling warns of life-threatening respiratory depression, QT prolongation/torsades de pointes, accidental ingestion, misuse and drug interactions. Assess QT risk factors, history of syncope, electrolyte abnormalities, interacting QT-prolonging drugs and clinically indicated ECG testing. Do not presume that a fixed ECG schedule is adequate for every person or that a stable previous opioid dose guarantees methadone tolerance [2].
Sedatives, pregnancy and overdose
Alcohol, benzodiazepines and gabapentinoids can increase respiratory depression. OUD treatment should not be categorically withheld due to concurrent benzodiazepine use; instead provide enhanced assessment, coordinated management and monitoring. Methadone treatment during pregnancy is an established approach to OUD; neonatal opioid withdrawal is expected in some newborns and requires prepared neonatal support. Accidental pediatric ingestion may be fatal. Provide naloxone access and secure storage [2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- DailyMed. METHADOSE (methadone hydrochloride) oral concentrate: US prescribing information, updated April 27, 2026. Available from: https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=808a9d0b-720b-4034-a862-5122ff514608
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.